The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...
The Company has been granted Competitive Generic Therapy designation, which allows for 180 days of marketing exclusivity.
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...
Worcester Telegram on MSN6d
MA lawmakers send Healey bill to cap some drug costs, regulate pharmacy benefit mangersPatients would pay no more than $25 for certain name-brand medications to treat chronic illnesses, and face no costs for ...
FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...
The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...
The ongoing shortage of liraglutide injection and other GLP-1 medications prompted the FDA to prioritize the generic drug applications for these medications in order to improve patient access.
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback